Rx for Biotech
Podcast Host Chris Leidli
Add to My Podcasts
Episodes
About
Reviews
Promote
Novel Immunotherapy approaches to engaging the Innate Immune System
15 minutes
Posted Jul 6, 2023 at 12:27 pm.
0:00
15:00
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
In this podcast episode, Dr. Michael Alonso, VP of Immunology and Pharmacology at Bolt Biotherapeutics, discusses how the company is developing cancer therapies that engage the innate immune system to generate robust anti-tumor responses.
Previous
Emerging Therapies for Rare Genetic Mitochondrial Diseases
Next
How Virax Biolabs is Developing a Potentially Game-Changing Immunology Platform for T-Cell Testing
← See all 90 episodes of Rx for Biotech